Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prasugrel vs High-Dose Clopidogrel in T2DM with CAD
NCT00642174Phase 2Completed
- Sponsor
- Eli Lilly and Company
- Start
- Apr 2008
- Primary completion
- Jan 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of prasugrel in coronary artery disease (CAD), sponsored by Eli Lilly and Company. Started Apr 2008; status: completed.
02
Drugs
prasugrel
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT00642174.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00642174.